Delivery Order SPE2DB22D1017-SPE2DB24FG0EG

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a wide range of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical program. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to deliver medications, specialty drugs, and critical care materials to DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,438.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is part of a larger single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. government awarded a Delivery Order contract worth $1,669.95 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, with a period of performance through May 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,129.44 to provide pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. The order is placed under a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical, in support of the Department of Defense (DoD) and other government agencies. The contract has an Indefinite Delivery Contract (IDC) vehicle valued up to $999,999,999.00 through December 31, 2025, serving as the primary means for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $1,446.66 for the provision of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medications, including specialty, brand name, generic, and...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to provide a wide range of pharmaceutical products and medical supplies. The contract, valued at up to $6,567.62, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order valued at $3,401.78. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to provide pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG0EG
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of pharmaceutical products and medical supplies. The $1,731.44 firm-fixed-price delivery order has a completion date of June 27, 2024 and is not associated with a set-aside program.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/25/24, 9:11 AM